Search

Fibrinolysin

The ointment is marketed by Pfizer under the brand name Fibrolan in a variety of countries (e.g. Switzerland). It is currently not approved in the USA.

Scorpion (centruroides) immune Fab2 antivenin (equine)

Severe scorpion stings may cause loss of muscle control and respiratory failure, warranting heavy sedation and hospitalization in an intensive care unit. … Envenomation by a scorpion sting can result in serious cardiovascular effects [A32483].

Carbomer homopolymer type C

Carbomer homopolymer type C is a high molecular polyanionic substance tested for antiulcerogenic activity.

Potassium triiodide

Ioglunide

Ioglunide is a small molecule drug. Ioglunide has a monoisotopic molecular weight of 806.86 Da.

INGN 225

INGN 225 is currently in Phase 1/2 trials in patients with small cell lung cancer and breast cancer. … INGN 225 is a therapeutic consisting of a cancer patient's own immune cells treated with an adenovector carrying the human p53 gene, Ad-p53.

Cilazaprilat

Rintodestrant

Rintodestrant is under investigation in clinical trial NCT03455270 (G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer).

XL019

An IND for XL019 was filed by Exelixis in May 2007.

Nomifensine

The approved application holder removed Merital capsules from the market on January 23, 1986. … Nomifensine, formerly marketed as Merital capsules, was associated with an increased incidence of hemolytic anemia.